订阅小程序
旧版功能

A Randomized Phase II Trial of Nab‐paclitaxel and Gemcitabine with Tarextumab or Placebo in Patients with Untreated Metastatic Pancreatic Cancer

Zishuo Ian Hu,Johanna C. Bendell,Andrea Bullock,Noelle K. LoConte,Hassan Hatoum,Paul Ritch,Hugo Hool,Joseph W. Leach,James Sanchez,Davendra P. S. Sohal,John Strickler,Ravindranath Patel,Andrea Wang-Gillam,Irfan Firdaus,Kenneth H. Yu,Ann M. Kapoun,Eric Holmgren,Lei Zhou,Jakob Dupont,Vincent Picozzi,Vaibhav Sahai,Eileen M. O'Reilly

Cancer Medicine（2019）

引用 67|浏览101
关键词
cancer stem cell,gemcitabine,nab-paclitaxel,Notch 2,3 receptor inhibitor,Pancreatic cancer,tarextumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要